Skip to main content

Day: May 2, 2022

NV5 Awards 2022 National Society of Black Engineers Scholarships

HOLLYWOOD, Fla., May 02, 2022 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of compliance, technology, engineering, and environmental consulting solutions, announced today that it has selected the 2022 NV5 National Society of Black Engineers (NSBE) scholarship award winners. The ten scholarship awards for 2022 are part of NV5’s five-year $275,000 commitment to NSBE. Scholarships were awarded to undergraduate and graduate level students across the country studying a variety of disciplines, including technology and civil, electrical, and mechanical engineering. Award recipient selection was based on personal essays, educational accomplishments, positive contributions to the community, and professional recommendations. These award winners embody the NSBE mission “to increase the number of...

Continue reading

Thomas A. Sa Appointed President of California BanCorp and California Bank of Commerce

OAKLAND, Calif., May 02, 2022 (GLOBE NEWSWIRE) — California BanCorp (the “Company”) (Nasdaq: CALB), the parent company of California Bank of Commerce (the “Bank”), today announced that Thomas A. Sa has been appointed President of the Company and the Bank, effective immediately. Mr. Sa will continue in his roles as Chief Financial Officer and Chief Operating Officer of the Company and the Bank. Steven E. Shelton, who previously held the position of President of the Company and the Bank, will remain as Chief Executive Officer of the Company and the Bank. “The separation of the President and CEO roles reflects the growth of the Company and the management structure we believe is best suited to continue effectively executing on the strategies that are enhancing the value of our franchise,” said Steven E. Shelton, Chief Executive Officer...

Continue reading

Aequus Announces Short Term Loan

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) announces that it has entered into an agreement with Mr. Doug Janzen, Chairman and Chief Executive Officer of the Company, pursuant to which Mr. Janzen will provide short-term financing to Aequus by way of an unsecured demand loan of C$2 million (the “Loan”). The purpose of the financing is to allow the Company to pay off the existing convertible debentures maturing May 2, 2022. Grant Larsen, Aequus’ Chief Commercial Officer, stated: “We are thankful for Doug’s investment. His continued confidence in our ability to provide cost-effective and high-quality solutions to meet both patient and physician needs. The proceeds from the note will enable us to repay the convertible debentures maturing...

Continue reading

Treace Secures Up to $150 Million in Debt Financing

PONTE VEDRA, Fla., May 02, 2022 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that it has entered into a new five-year $150 million loan arrangement with MidCap Financial, comprising up to $120 million in term loans and a $30 million revolving credit facility. Proceeds from the new term loan refinanced the Company’s existing $30 million term loan from CR Group LP. In addition, the new revolving credit facility will expand the Company’s revolving credit capacity and replace the undrawn existing $10 million revolving credit facility from Silicon Valley Bank. “We are pleased to secure this non-dilutive debt financing with favorable terms, providing...

Continue reading

TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)

Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing Technology in the Fight Against COVID-19 Members of Dr. Williams’ Lab at The University of Texas at Austin will Present Five Posters at RDD Meeting Research Showcases Versatility and Differentiation of the Thin Film Freezing Technology Platform and its Potential to Address Multiple Challenges in Drug Development of Biologics Dr. Williams and Colleagues Also Published New Research Demonstrating Significant Advantages of Thin Film Freezing Over Conventional Dry Freezing FORT WORTH, Texas, May 02, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing...

Continue reading

CAPREIT Continues to Invest in Affordable Housing and Value Creation

TORONTO, May 02, 2022 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today that it had completed the purchase of a 172-site Manufactured Housing Community (“MHC”) located in Red Deer, Alberta. The community, developed in 2000, was acquired for $16.5 million, funded with existing liquidity. Occupancy was 100% at closing. “With this acquisition, we now own and operate 77 manufactured housing communities, well-located in key markets across Canada totaling 12,375 MHC sites,” commented Mark Kenney, President and CEO. “Looking ahead, we will continue to further diversify our residential portfolio, including a strong focus on the MHC sector due to its contribution to housing affordability, the strength and stability of its revenue streams, and the attractive return profile.” “Over...

Continue reading

Ackroo makes changes to their Board of Directors

HAMILTON, Ontario, May 02, 2022 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a loyalty marketing, payments and point-of-sale technology and services provider, announces changes to their board of Directors. Each of Francis Shen, Jason Donville and Kristaps Ronka will step down from the board effective immediately to be replaced by new board members. “As we look forward with Ackroo, we collectively agreed to make changes to our Board of Directors to align with our strategic direction,” said Steve Levely, CEO of Ackroo. “We felt that the vision would be best served with attracting new board members with strong strategic alignment as we plan for the next phase of growth at Ackroo. I would like to thank each of Kristaps, Jason and Francis for their involvement and support of Ackroo and wish them the best...

Continue reading

Option Care Health to Participate in Upcoming Investor Conference

BANNOCKBURN, Ill., May 02, 2022 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the BofA Securities 2022 Healthcare Conference, being held in Las Vegas, on Tuesday, May 10, 2022, including a fireside chat presentation at 11:20am P.T. An audio-only replay will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,000 team members, including more than 4,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise...

Continue reading

Xtant Medical Appoints Scott Neils as Chief Financial Officer

BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Chief Financial Officer, effective June 1, 2022. “Scott’s success and experience during his tenure at Xtant, including his recent position as interim Chief Financial Officer, makes him an invaluable member of our team,” said Sean Browne, President and Chief Executive Officer of Xtant Medical. “Scott’s continued contributions will be instrumental as we execute on our growth strategy and deliver on our mission of ‘honoring the gift of donation.’” Mr. Neils has more than 15 years of experience focused on public accounting and corporate finance, and has served as interim Chief Financial...

Continue reading

Pennant Acquires Home Health Provider, Senior Living Real Estate Asset

EAGLE, Idaho, May 02, 2022 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired the assets of First Choice Home Health, which provides home health and personal care services in Bozeman, Montana. The acquisition was effective May 1, 2022. “We are excited to expand and strengthen our presence in Montana,” said Brent Guerisoli, President of Pennant. “This acquisition complements our existing hospice operations in the state, expanding the continuum of care services we can provide our patients and their families, and opens the door to greater expansion within the region. Our acquisition pipeline is robust, and we look forward to further activity this year in existing and new markets...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.